Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Regulatory press release

Disclosure of Large Shareholding - Nykode Therapeutics ASA

Nykode Therapeutics
Please find the attached notifications as of 10 October 2025 submitted on behalf
of The Capital Group Companies, Inc. ("CGC") and SMALLCAP World Fund, Inc.
("SCWF") due to the purchase of shares.

Please note that the notification submitted on behalf of CGC as of 10 October
2025 included SCWF's holdings.

SCWF is a mutual fund registered in the United States under the Investment
Company Act of 1940. SCWF is the legal owner of the 16,387,015 shares held
(5.018% of total voting rights and 5.018% of total share capital) as of 10
October 2025. SCWF has granted proxy voting authority to Capital Research and
Management Company ("CRMC"), its investment adviser. As noted in the letter, CGC
is the parent company of CRMC.

Please see attachments on www.newsweb.no
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.